The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-((1R,2S,3R)-3-hydroxy-2-(4-(1-hydroxycyclobutyl)phenyl)-5-oxocyclopentyl)hept-5-enoic acid ID: ALA3985882
PubChem CID: 58681359
Max Phase: Preclinical
Molecular Formula: C22H28O5
Molecular Weight: 372.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCC/C=C\C[C@H]1C(=O)C[C@@H](O)[C@@H]1c1ccc(C2(O)CCC2)cc1
Standard InChI: InChI=1S/C22H28O5/c23-18-14-19(24)21(17(18)6-3-1-2-4-7-20(25)26)15-8-10-16(11-9-15)22(27)12-5-13-22/h1,3,8-11,17,19,21,24,27H,2,4-7,12-14H2,(H,25,26)/b3-1-/t17-,19+,21+/m0/s1
Standard InChI Key: IYUJRRJWUAAMRV-VPDRBAPTSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.7281 -20.5597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0182 -20.9642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4227 -21.6741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1326 -21.2696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9934 -17.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8106 -17.9122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0650 -17.1355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4020 -16.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7433 -17.1355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4008 -15.8362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5122 -18.5727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2902 -18.5739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9538 -19.3183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4327 -19.9796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0981 -18.4863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8425 -16.8840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4491 -17.4317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2266 -17.1803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3976 -16.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1752 -16.1297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3462 -15.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1237 -15.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7302 -15.6268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2947 -14.2801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5790 -19.1444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2484 -19.8970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5418 -20.4719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 2 0
5 11 1 6
6 12 1 1
12 13 2 0
13 14 1 0
14 26 2 0
25 15 2 0
15 12 1 0
7 16 1 6
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
22 24 1 0
25 26 1 0
26 1 1 0
1 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.46Molecular Weight (Monoisotopic): 372.1937AlogP: 3.29#Rotatable Bonds: 8Polar Surface Area: 94.83Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.29CX Basic pKa: ┄CX LogP: 2.91CX LogD: -0.07Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.48Np Likeness Score: 1.56
References 1. (2010) Therapeutic compounds,